Data readout from the maintenance dosing study of VK2735, the company’s investigational obesity candidate, is expected in the ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Zacks Investment Research on MSN
Viking Therapeutics, Inc. (VKTX) exceeds market returns: Some facts to consider
In the latest close session, Viking Therapeutics, Inc. (VKTX) was up +1.53% at $29.78. The stock outpaced the S&P 500's daily gain of 0.41%. On the other hand, the Dow registered a gain of 1.73%, and ...
GLP-1 drugs, the treatment class popularized by Eli Lilly (LLY) and Novo Nordisk (NVO), could generate $150B in global sales ...
With 21 equities in the portfolio, Dana Unconstrained Equity ETF has a solid mix of growth and quality characteristics. Read ...
Most of the market's best-known growth names are overbought at this time. That's not the case for several off-the-radar ...
While those timelines might not seem exciting, investors should note that Viking is due to release results from an extremely ...
Novo Nordisk is rated a strong buy, offering a 4.2% yield and trading at a 40% discount to fair value. Click here to read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results